Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

RenovoRx (RNXT) Gains from Sales and Divestitures (2024 - 2025)

Historic Gains from Sales and Divestitures for RenovoRx (RNXT) over the last 2 years, with Q3 2025 value amounting to $4.0 million.

  • RenovoRx's Gains from Sales and Divestitures rose 8054000.0% to $4.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $4.0 million, marking a year-over-year increase of 8054000.0%. This contributed to the annual value of $5000.0 for FY2024, which is N/A changed from last year.
  • Per RenovoRx's latest filing, its Gains from Sales and Divestitures stood at $4.0 million for Q3 2025, which was up 8054000.0% from $5000.0 recorded in Q4 2024.
  • In the past 5 years, RenovoRx's Gains from Sales and Divestitures ranged from a high of $4.0 million in Q3 2025 and a low of $5000.0 during Q2 2024